| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/19/2011 | US20110117072 Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
| 05/19/2011 | US20110117063 Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells For Treatment of Retinal Degeneration |
| 05/19/2011 | US20110117062 Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells |
| 05/19/2011 | US20110117058 Method of treating genetic disorders |
| 05/19/2011 | US20110117049 Methods and Compositions for Modulating Adipocyte Function |
| 05/19/2011 | CA2780563A1 Antisense molecules and methods for treating pathologies |
| 05/18/2011 | EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms. |
| 05/18/2011 | EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms. |
| 05/18/2011 | EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms. |
| 05/18/2011 | EP2322638A1 AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| 05/18/2011 | EP2322626A1 HIV-GAG codon-optimised DNA vaccines |
| 05/18/2011 | EP2322618A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 05/18/2011 | EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy |
| 05/18/2011 | EP2322614A1 Recombinational cloning using engineered recombination sites |
| 05/18/2011 | EP2322608A1 Transfection agent |
| 05/18/2011 | EP2322601A1 Method of collecting placental stem cells |
| 05/18/2011 | EP2322224A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 05/18/2011 | EP2322199A1 Growth differentiation factor receptors, and methods of using same |
| 05/18/2011 | EP2322186A2 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 05/18/2011 | EP2322185A2 Polynucleotide therapy |
| 05/18/2011 | EP2322143A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| 05/18/2011 | EP2321346A1 Methods and substances for stimulating muscle regeneration |
| 05/18/2011 | EP2320953A2 Long-acting dna dendrimers and methods thereof |
| 05/18/2011 | EP2320952A1 IMPROVED PRE-mRNA TRANS-SPLICING MOLECULE (RTM) MOLECULES AND THEIR USES |
| 05/18/2011 | EP2320935A1 Soluble igf receptors as anti-angiogenic agents |
| 05/18/2011 | EP2320931A2 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 05/18/2011 | EP1238089B1 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 05/18/2011 | EP1032595B1 Nucleic acids involved in the responder phenotype and applications thereof |
| 05/18/2011 | CN1958788B Gene recombined virus of human neurenergen 3 |
| 05/18/2011 | CN1744821B Methods and application using compounds from fetal cells and tissues to improve condition of skin |
| 05/18/2011 | CN102066444A Micellic assemblies |
| 05/18/2011 | CN102066412A Treatment of diseases and conditions mediated by eicosanoids |
| 05/18/2011 | CN102065902A Polymeric carrier |
| 05/18/2011 | CN102061310A Construction and application of human FHL1C eukaryotic expression vector |
| 05/18/2011 | CN102061304A Establishment and application of mice Leptin super-expression vector |
| 05/18/2011 | CN102060723A Preparation method of cationic liposome nanoparticles of amino acid |
| 05/18/2011 | CN102058535A Novel folate receptor targeted liposome |
| 05/18/2011 | CN101210255B Recombination ferroportin adenovirus, preparation method and application thereof |
| 05/18/2011 | CN101209351B Ankara vaccinia virus genetic engineering vaccine for pig replication and respiration complex |
| 05/18/2011 | CN101072875B Novel cancer antigen peptide and the use thereof |
| 05/17/2011 | USRE42373 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/17/2011 | US7943815 A reporter gene, the transcription of which is inducible by natural or synthetic molecule which modulate the activity of such reporter, is incorporated into the genome of the animal to produce nonhuman transgenic animal |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943591 Gene expression and pain |
| 05/17/2011 | US7943590 Compositions and methods for treating ophthalmic disorders |
| 05/17/2011 | US7943588 Method for preventing or treating neuropathic pain |
| 05/17/2011 | US7943587 Administering to the individual, one or more nucleic acid molecules that comprise a nucleotide sequence that encodes an immunogen and a nucleotide sequence that encodes an Major Histocompatibility Complex antigen |
| 05/17/2011 | US7943581 Cell penetrating peptides for intracellular delivery of molecules |
| 05/17/2011 | US7943378 Tissue engineering |
| 05/17/2011 | US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/17/2011 | US7943179 Drug delivery particle; useful in genetic vaccination; eg poly(beta-amino esters) |
| 05/17/2011 | US7943147 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 05/17/2011 | US7943146 Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface |
| 05/17/2011 | US7943144 Herpes simplex virus complex |
| 05/17/2011 | US7943125 Attenuated gram negative bacteria |
| 05/17/2011 | US7943122 Attenuated bacteria useful in vaccines |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2361943C Genetic modification of somatic cells and uses thereof |
| 05/17/2011 | CA2320100C High affinity nucleic acid ligands of complement system proteins |
| 05/17/2011 | CA2228221C Papillomavirus polyprotein constructs |
| 05/12/2011 | WO2011057243A2 Administration of plant expressed oral tolerance agents |
| 05/12/2011 | WO2011057118A1 Anti-apoptotic agents and uses thereof |
| 05/12/2011 | WO2011057020A1 Activity generating delivery molecules |
| 05/12/2011 | WO2011056005A2 Novel sirna structure for minimizing off-target effects caused by antisense strands, and use thereof |
| 05/12/2011 | WO2011055888A1 Nanoparticle-based gene delivery systems |
| 05/12/2011 | WO2011054976A2 Novel viral vector construct for neuron specific optimized continuous dopa synthesis in vivo |
| 05/12/2011 | WO2011008730A3 Chemical modification of small hairpin rnas for inhibition of gene expression |
| 05/12/2011 | WO2010151640A3 Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease |
| 05/12/2011 | WO2010144908A3 Mammalian genes involved in tularemia and other infections |
| 05/12/2011 | WO2010137900A9 Selective infracted-tissue-targeting bacteria and use thereof |
| 05/12/2011 | WO2010135695A3 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3 |
| 05/12/2011 | WO2010129861A3 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
| 05/12/2011 | US20110112510 Methods, compositions and apparatus for delivering heterologous molecules to cells |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112179 Cell line, system and method for optical control of secondary messengers |
| 05/12/2011 | US20110111983 siRNA targeting spleen tyrosine kinase |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111505 Genetically engineered cells which express bone morphogenic proteins |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111491 Rna interference suppresion of neurodegenerative diseases and methods of use thereof |
| 05/12/2011 | US20110111398 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110960 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
| 05/12/2011 | US20110110958 Compositions and methods for the treatment of neoplasia |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110902 Means and methods for counteracting, delaying and/or preventing heart disease |
| 05/12/2011 | US20110110887 Recombinant herpesvirus of turkeys encoding for interleukin-12 |
| 05/12/2011 | CA2817014A1 Activity generating delivery molecules |
| 05/12/2011 | CA2780362A1 Administration of plant expressed oral tolerance agents |
| 05/12/2011 | CA2779437A1 Novel viral vector construct for neuron specific continuous dopa synthesis in vivo |
| 05/11/2011 | EP2319866A2 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 05/11/2011 | EP2319543A1 RNAi inhibition of CTGF for treatment of ocular disorders |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319529A1 Methods for treating congestive heart failure |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2318434A1 Her2/neu specific t cell receptors |
| 05/11/2011 | EP2038415B1 Dph2 gene deletion mutant and uses thereof |